AS2575959, identified by its CAS number 1616871-34-1, is a chemical compound that falls within the category of small molecules, often utilized in pharmaceutical research and development. While specific characteristics such as molecular weight, structure, and functional groups are not detailed in the provided information, compounds like AS2575959 typically exhibit properties that are relevant to their biological activity, including solubility, stability, and reactivity. These compounds are often evaluated for their potential therapeutic effects, mechanisms of action, and safety profiles. In the context of drug discovery, they may undergo various assays to determine their efficacy against specific biological targets. Additionally, the compound's physicochemical properties, such as melting point, boiling point, and spectral data, are crucial for understanding its behavior in biological systems and its suitability for formulation into drug products. For precise characteristics, including detailed structural information and specific applications, consulting scientific literature or databases dedicated to chemical substances is recommended.

AS2575959 is a novel GPR40 agonist, exhibiting glucose metabolism improvement and synergistic effect with sitagliptin on insulin and incretin secretion.

AS2575959

1616871-34-1: AS2575959, identified by its CAS number 1616871-34-1, is a chemical compound that falls within the category of small molecules, often utilized in pharmaceutical research and development. While specific characteristics such as molecular weight, structure, and functional groups are not detailed in the provided information, compounds like AS2575959 typically exhibit properties that are relevant to their biological activity, including solubility, stability, and reactivity. These compounds are often evaluated for their potential therapeutic effects, mechanisms of action, and safety profiles. In the context of drug discovery, they may undergo various assays to determine their efficacy against specific biological targets. Additionally, the compound's physicochemical properties, such as melting point, boiling point, and spectral data, are crucial for understanding its behavior in biological systems and its suitability for formulation into drug products. For precise characteristics, including detailed structural information and specific applications, consulting scientific literature or databases dedicated to chemical substances is recommended.

<p>AS2575959 is a novel GPR40 agonist, exhibiting glucose metabolism improvement and synergistic effect with sitagliptin on insulin and incretin secretion.</p>

CAS 1616871-34-1

AS2575959

AS2575959

Ref: TM-T70373